Anhydroretinol, a retinoid active in preventing mammary cancer induced in rats by N-methyl-N-nitrosourea

Oncology Reports

Volumn 5, Issue 4, 1998, Pages 857-860

  Shealy, Y Fulmer ^a   Hill, Donald L ^a,b   Sani, Brahma P ^a   Eto, Isao ^b   Juliana, M Margaret ^c   Grubbs, Clinton J ^b  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Anhydroretinol; Cellular retinol binding protein; Chemoprevention; Mammary cancer; Serum retinol binding protein

Indexed keywords

ALPHA TOCOPHEROL; CELL NUCLEUS RECEPTOR; DRUG VEHICLE; METHYLNITROSOUREA; RETINOIC ACID; RETINOIC ACID BINDING PROTEIN; RETINOID; RETINOL ACETATE; RETINOL BINDING PROTEIN; RETINOL PALMITATE; TRIOCTANOIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0031865118     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.4.857     Document Type: Article

References (32)

1. Lotan R: Effect of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 605: 33-91, 1981.
2. Gudas LJ, Sporn MB and Roberts AB: Cellular biology and biochemistry of the retinoids. In: The Retinoids. 2nd edition. Sporn MB, Roberts AB and Goodman DS (eds.) Raven Press, New York, pp443-520, 1994.
3. Lippmann SM, Kessler JF and Meyskens FL: Retinoids as preventive and therapeutic anticancer agents. Cancer Treat Rep 71: 493-515, 1987.
4. Hill DL and Grubbs CJ: Retinoids and cancer prevention. Ann Rev Nutr 12: 161-181, 1992.
5. Sani BP, Condon SM and Banerjee CK: Purification and properties of retinol- and retinoic acid-binding proteins from a transplantable mouse colon tumor. Biochim Biophys Acta 624: 226-236, 1980.
6. Mangelsdorf DJ, Thummel C, Besto M, Herrlich P, Schutz G, Umesowo K, Blumberg B, Kastner P, Marie M, Chambon P and Evans RM: The nuclear receptor superfamily: the second decade. Cell 83: 835-839, 1995.
7. Lindamood C III, Dillehay DL, Lamon EW, Giles HD, Shealy YF, Sani BP and Hill DL; Toxicologic and immunologic evaluations of N-(all-trans-retinoyl)-DL-leucine and N-(all-trans-retinoyl) glycine. Toxicol Appl Pharmacol 96: 279-295, 1988.
8. Bhat PV, De Luca LM, Adamo S, Akalovsky I, Silverman-Jones CS and Peck GL: Retinoid metabolism in spontaneously transformed mouse fibroblasts (Balb/c 3T12-3 cells): enzymatic conversion of retinol to anhydroretinol. J Lipid Res 20: 357-362, 1979.
9. Muto Y and Moriwaki H: Antitumor activity of vitamin A and its derivatives. J Natl Cancer Inst 73: 1389-1393, 1984.
10. Buck J, Grün F, Derguini F, Chen Y, Kimura S, Noy N and Hämmerling U: Anhydroretinol: a naturally occurring inhibitor of lymphocyte physiology. J Exp Med 178: 675-680, 1993.
11. Eppinger TM, Buck J and Hammering U: Growth control or terminal differentation: endogenous production and differential activities of vitamin A metabolites in HL-60 cells. J Exp Med 178: 1995-2005, 1993.
12. Duell EA, Derguini F, Kang S, Elder JT and Voorhees JJ: Extraction of human epidermis treated with retinol yields retroretinoids in addition to free retinol and retinyl esters. J Invest Dermatol 107: 178-182, 1996.
13. Grün F, Noy N, Hämmerling U and Buck J: Purification, cloning and bacterial expression of retinol dehydratase from Spodoptera frugiperda. J Biol Chem 271: 16135-16138, 1996.
14. Edisbury JR, Gillam AE, Heilbron IM and Morton RA: Absorption spectra of substances derived from vitamin A. Biochem J 26: 1164-1173, 1932.
15. Shantz EM, Cawley JD and Embree ND: Anhydro ('cyclized') vitamin A. J Am Chem Soc 65: 901-906, 1943.
16. Shealy YF, Riordan JM, Frye JL and Campbell SR: Intramolecular Diels-Alder reactions of the retinoid side chain. Tetrahedron 52: 405-424, 1996.
17. Derguini F, Nakanishi K, Buck J, Hämmerling U and Grün F: Spectroscopic studies of anhydroretinol, an endogenous mammalian and insect retro-retinoid. Angew Chem Intern Ed Engl 33: 1837-1839, 1994.
18. Fex G, Laurell CB and Thulin E: Purification of prealbumin from human and canine serum using a two-step affinity Chromato-graphic procedure. Eur J Biochem 75: 181-186, 1977.
19. Venepally P, Reddy LG and Sani BP: Analysis of the effects of CRABP I expression on the RA-induced transcription mediated by retinoid receptors. Biochemistry 35: 9974-9982, 1996.
20. Venepally P, Reddy LG and Sani BP: Analysis of homo- and hetero-dimerization of retinoid receptors in solution. Arch Biochem Biophys 343: 234-242, 1997.
21. Grubbs CJ, Steele VE, Casebolt T, Juliana MM, Eto I, Whitaker LM, Dragnev KH, Kelloff GJ and Lubet RL: Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 15: 709-716, 1995.
22. Shealy YF, Frye JL, Riordan JM, Hill DL, McPhillips M, Wille JJ, Sani BP, Kalin JR, Eto I and Grubbs CJ: Retmyl ethers as cancer chemopreventive agents. Suppression of mammary cancer. Anticancer Drug Des 12: 15-33, 1997.
23. Peto J: The calculation and interpretation of survival curves. In: Cancer Clinical Trials: Methods and Practice. Buyse ME, Staquet MJ and Sylvester RJ (eds.) Oxford University Press, Oxford, pp361-380, 1984.
24. Armitage P: The Chi-square test for heterogeneity of proportion after adjustment for stratification. J R Statist Soc B 28: 150-163, 1966.
25. O'Connell MJ, Chua R, Hoyos B, Buck J, Chen Y Derguini F and Hämmerling U: Retro-retinoids in regulated cell growth and death. J Exp Med 184: 549-555, 1996.
26. Grubbs CJ, Eto I, Juliana MM, Hardin JM and Whitaker LM: Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors. Anticancer Res 10: 661-666, 1990.
27. Hill DL and Grubbs CJ: Intestinal absorption of nutrients in animals dosed orally with retinoids: Considerations for chemopreventive studies. Cancer Invest 3: 243-248, 1985.
28. Thompson HJ, Becci PJ, Moon RC, Sporn MB, Newton DL, Brown CC, Nürrenbach A and Paust J: Inhibition of 1-methyl-1-nitrosourea-induced mammary carcinogenesis in the rat by the retinoid axerophthene. Arzneim-Forsch/Drug Res 30: 1127-1129, 1980.
29. Newton DL, Frolik CA, Roberts AB, Smith JM, Sporn MB, Nurrenbach A and Paust J: Biological activity and metabolism of the retinoid axerophthene (vitamin A hydrocarbon). Cancer Res 38: 1734-1738, 1978.
30. Buck J, Derguini F, Levi E, Nakanishi K and Hämmerling U: Intracellular signaling by 14-hydroxy-4,14-mro-retinol. Science 254: 1654-1655, 1991.
31. Derguini F, Nakanishi K, Hämmerling U, Chua R, Eppinger T, Levi E and Buck J: 13,14-Dihydroxy-retinol, a new bioactive retinol metabolite. J Biol Chem 270: 18875-18880, 1995.
32. Derguini F, Nakanishi K, Hämmerling U and Buck J: Intracellular signaling activity of synthetic (14R)-, (145)- and (14RS)-14-hydroxy-4,14-rerro-retinol. Biochemistry 33: 623-628, 1994.